A 55-Year-Old Man with Muscle-Invasive Bladder Cancer - Episode 1

Case Presentation: A 55-Year-Old Man with Muscle-Invasive Bladder Cancer (MIBC)

Matthew Galsky, MD, presents the case of a 55-year-old man with stage T2N0M0 muscle-invasive bladder cancer (MIBC) for review, and explains how cisplatin eligibility is defined in patients.

Now Viewing
EP. 1: Case Presentation: A 55-Year-Old Man with Muscle-Invasive Bladder Cancer (MIBC)
EP. 2: Available Adjuvant Therapy Options After Cystectomy for Patients with Stage II or III MIBC
EP. 3: Safety and Efficacy Data from CheckMate 274 on Adjuvant Nivolumab Therapy for Patients with MIBC
EP. 4: Adjuvant Therapy Regimen Considerations for Patients with MIBC
EP. 5: Critical Unmet Needs for Patients with MIBC and Ongoing Clinical Trials in the Neoadjuvant Setting
EP. 6: Approaches to Neoadjuvant and Adjuvant Immunotherapy for Patients with MIBC